InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Reinhard Amy, 董事. Director active across 2 companies, notably Gannett Co., Inc.. In total, 8 reports have been recorded. History available since 7 June 2022. The latest transaction was filed on 31 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Amy E. McKee is a Director at BIOCRYST PHARMACEUTICALS INC. She contributes to corporate governance and the strategic direction of the company. As a board member, she participates in important decision-making and oversight of BIOCRYST's operations. Her experience in the biopharmaceutical sector is an asset for the company.